Clinical Trials on Perennial Allergic Rhinitis

Total 2980 results

Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis

Chronic Rhinosinusitis With Nasal Polyps

China
Sanofi

Active, not recruiting

Dupilumab in Chinese Adult Participants With CRSwNP

Chronic Rhinosinusitis With Nasal Polyps

China
King Abdulaziz Medical City
Merck Sharp & Dohme LLC

Unknown

Prevalence of Asthma and Rhinitis Symptoms Among Secondary School Students in Saudi Arabia

Asthma | Rhinitis
Medical University of Vienna

Completed

TBE (Tick-borne Encephalitis) Vaccination in Allergic Patients

Vaccine Responsiveness in Allergy | Vaccine Responsiveness During Allergy De-sensitization Treatment

Austria
Stallergenes Greer
Monitoring Force Group

Completed

Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma (PROTECT)

Allergy
Karolinska Institutet
Karolinska University Hospital; Sahlgrenska University Hospital, Sweden; Region... and other collaborators

Recruiting

SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION (SAID)

Autoimmune Diseases | Allergy | Immunodeficiency | Autoinflammatory Syndrome | Dysregulated Host Response

Sweden
Medical University of Warsaw

Recruiting

Induction of Sustained Unresponsiveness to Peanuts Using High- and Low-dose Peanut Oral Immunotherapy

Peanut Allergy

Poland
Medical University of Warsaw

Recruiting

High and Low Dose Oral Peanut Immunotherapy - Comparison of Efficacy and Safety

Peanut Allergy

Poland
Guy's and St Thomas' NHS Foundation Trust
King's College London; Imperial College London; National Institute for Health...

Completed

The Grown Up Peanut Immunotherapy Study (GUPI)

Peanut Allergy

United Kingdom
DBV Technologies
Todd D. Green MD, DBV Technologies

Available

Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children

Peanut Allergy

United States
Astellas Pharma Global Development, Inc.

Completed

A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine

Peanut Allergy

United States
Astellas Pharma Global Development, Inc.

Completed

A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine

Peanut Allergy

United States
Aimmune Therapeutics, Inc.

Completed

Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES) (RAMSES)

Peanut Allergy

United States, Canada
DBV Technologies

No longer available

Viaskin® Peanut (DBV712) Expanded Access Protocol

Peanut Allergy
DBV Technologies

Active, not recruiting

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age (EPITOPE)

Peanut Allergy

United States, Canada, Australia, France, Germany, United Kingdom, Ireland, Netherlands
Regeneron Pharmaceuticals

Completed

Single Ascending-dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Participants

Allergy

United Kingdom, New Zealand, Netherlands, Sweden
University Hospital, Montpellier

Terminated

Validation of the HYPONUT Product

Peanut Allergy

France
McMaster University
AllerGen NCE Inc.

Unknown

Canadian Peanut Thresholds Study

Peanut Allergy

Canada
Massachusetts General Hospital
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

High Threshold Peanut Challenge Study (PAID-UP)

Peanut Allergy
University of Wisconsin, Madison
National Center for Complementary and Integrative Health (NCCIH)

Completed

Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy

Asthma

United States
University of North Carolina, Chapel Hill
University of Arkansas

Completed

Oral Immunotherapy for Peanut Allergy (PMIT) (PMIT)

Food Hypersensitivity

United States
University of North Carolina, Chapel Hill
North Carolina Agriculture & Technical State University

Completed

Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects (peanut)

Peanut Allergy

United States
Lynda Schneider

Completed

Xolair Enhances Oral Desensitization in Peanut Allergic Patients

Peanut Allergy

United States
ALK-Abelló A/S

Completed

A Trial of the ALK Grass Tablet in Subjects With Hayfever

Allergy

Denmark
ALK-Abelló A/S

Completed

Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets

Allergy

Spain
Medical University of Silesia

Completed

House Dust Mite Injection Immunotherapy in Elderly Patients. (HDMeld)

Allergen Immunotherapy in Elderly Patients
Celeste Chandonnet

Completed

Pilot Study: Safety of Chlorhexidine (CHG) Baths in Patients Less Than 2 Months of Age

Infection | Rash | Chlorhexidine Allergy

United States
University of Texas Southwestern Medical Center

Completed

Understanding How the Immune System Responds to Viruses in Peanut Allergic Children Undergoing Peanut Oral Immunotherapy (DCOIT)

Peanut Allergy

United States
Antigen Laboratories, Inc.

Completed

Phase 2 Study in Adults Sensitized to Cat

Allergy

United States
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Study of Dust Mite Inhalation in Humans

Allergy | Mild Asthma

United States
Jacqueline Wassenberg

Completed

Assessment of Quality of Life in Food Allergic Children

Food Allergy
Katrina Atef Habashy
Assiut University

Not yet recruiting

Predictive Factors in Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps
Upstream Bio Inc.

Recruiting

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps (VIBRANT)

Chronic Rhinosinusitis With Nasal Polyps

United States
Insmed Incorporated

Recruiting

A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) (BiRCh)

Chronic Rhinosinusitis Without Nasal Polyps

United States, Australia, Argentina, Canada, Bulgaria, Poland, Portugal, Czechia, France, Italy, Spain
AstraZeneca

Active, not recruiting

Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID) (ORCHID)

Nasal Polyposis

United States, Italy, Belgium, Taiwan, Thailand, Vietnam, France, Hungary, China, Japan, Australia, Argentina, Poland, Russian Federation, Turkey, Bulgaria, Chile
University of Rochester

Withdrawn

Early-onset Dupilumab Effects in CRSwNP

Chronic Rhinosinusitis With Nasal Polyps

United States
Centre hospitalier de l'Université de Montréal...

Active, not recruiting

Dupilumab for Prevention of Recurrence of CRSwNP After ESS

Chronic Rhinosinusitis With Nasal Polyps

Canada
Indonesia University

Completed

Sleep Disturbance in Chronic Rhinitis

Sleep Disturbance

Indonesia
Pixium Vision SA

Completed

Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy (IRIS 2)

Retinitis Pigmentosa | Choroideremia | Cone Rod Dystrophy

Austria, Spain, United Kingdom, France, Germany
Zheng Liu

Completed

Research on Identifying and Treatment Prognosis of Chronic Rhinosinusitis Based on Image and Sequencing Data

Progression | Chronic Sinusitis | Surgery | Radiology | Pathology

China
AstraZeneca
Amgen

Active, not recruiting

Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis (WAYPOINT)

Chronic Rhinosinusitis With Nasal Polyps

United States, Canada, Denmark, Spain, United Kingdom, Germany, Hungary, China, Japan, Poland
Organon and Co

Completed

Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria (Aerius)

Rhinitis | Urticaria
Cairo University

Completed

Study of Nasal Mucosa Histopathological Changes in Chronic Hypersensitivity Pneumonitis

Hypersensitivity Pneumonitis | Nasal Mucosal Disorder

Egypt
University of Sao Paulo General Hospital

Completed

Small Airway Involvement in Patients With Chronic Hypersensitivity Pneumonitis

Hypersensitivity Pneumonitis | Airway Disease Small

Brazil
ALK-Abelló A/S
Parexel

Completed

A Study in Children and Adolescents With Birch Pollen-induced Rhinoconjunctivitis (TreeTop)

Allergy

Hungary, Canada, Belgium, Poland, Austria, Germany, Denmark, Lithuania, Netherlands, Russian Federation, Slovakia
Allergopharma GmbH & Co. KG

Completed

Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens

Type I-Allergy

Germany
University of North Carolina, Chapel Hill
Genentech, Inc.; National Institutes of Health (NIH)

Terminated

Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab

Asthma | Allergy

United States
Lawson Health Research Institute
Mount Sinai Hospital, Canada

Recruiting

Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis

Chronic Rhinosinusitis With Nasal Polyps | Olfactory Disorder

Canada
Wake Forest University
UCB Pharma

Terminated

The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism

Rhinitis | Urticaria

United States
Penn State University

Completed

Non-Rhinologic Etiologies of Headaches and Facial Pain in Tertiary Care Setting

Sinusitis | Rhinitis | Headache | Facial Pain

United States

Clinical Trials on Perennial Allergic Rhinitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations